Sedation and antihistamines: An update. Review of inter-drug differences using proportional impairment ratios

Human Psychopharmacology

Volumn 23, Issue 7, 2008, Pages 555-570

  McDonald, Kathleen ^a   Trick, Leanne ^a   Boyle, Julia ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Antihistamines; Impairment; Performance; Proportional impairment ratio; Sedation

Indexed keywords

ACRIVASTINE; ANTIHISTAMINIC AGENT; AZATADINE; BROMPHENIRAMINE; CETIRIZINE; CHLORPHENIRAMINE; CLEMASTINE; CYCLIZINE; DESLORATADINE; DEXCHLORPHENIRAMINE; DIMENHYDRINATE; DIPHENHYDRAMINE; EBASTINE; EMEDASTINE; FEXOFENADINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HYDROXYZINE; KETOTIFEN; LEVOCETIRIZINE; LORATADINE; MECLOZINE; MEQUITAZINE; OLOPATADINE; OXATOMIDE; PLACEBO; PROMETHAZINE; RUPATADINE; TAZIFYLLINE; TRIPROLIDINE; UNINDEXED DRUG;

CALCULATION; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; DATA BASE; DRUG EFFICACY; HUMAN; MEMORY; METHODOLOGY; MOTOR PERFORMANCE; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOMETRY; PSYCHOMOTOR DISORDER; PSYCHOMOTOR PERFORMANCE; REVIEW; SEDATION; SENSORIMOTOR FUNCTION; SENSORY SYSTEM; SIDE EFFECT; VOLUNTEER;

COGNITION DISORDERS; DATABASES, BIBLIOGRAPHIC; HISTAMINE ANTAGONISTS; HUMANS; HYPERSENSITIVITY; HYPNOTICS AND SEDATIVES; PSYCHOMOTOR DISORDERS;

EID: 57149133829     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.962     Document Type: Review

References (48)

1. Acons KLS, Chan L, Drummond G, Tiplady B. 2006. Effects of ethanol and promethazine on awareness of errors and judgements of performance. J Psychopharmacol 20(5): 661-669.
2. Barbanoj MJ, García-Gea C, Morte A, Izquierdo I, Perez I, Jane F. 2004. Central and peripheral evaluation of rupatadine, a new antihistamine/platelet-activating factor antagonist, at different doses in healthy volunteers. Neuropsychobiology 50(4): 311-321.
3. Bender BG. 2005. Cognitive effects of allergic rhinitis and its treatment. Immunol Allergy Clin North Am 25(2): 301-312.
4. Bousquet J. 2003. Allergic rhinitis and its impact on asthma (ARIA). Clin Exp Allergy Rev 3(1): 43-45.
5. Bousquet J, Van Cauwenberge P, Khaltaev N. 2001. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 108(5): 147-334.
6. Bower EA, Moore JL, Moss M, Selby KA, Austin M, Meeves S. 2003. The effects of single dose fexofenadine, diphenhydramine, and placebo on cognitive performance in flight personnel. Aviat Space Environ Med 74(2): 145-152.
7. Boyle JEM, Stanley N, Fujita T, Kumagi Y. 2006. Allergy medication in Japanese volunteers: treatment effect of single doses on nocturnal sleep architecture and next day residual effects. Curr Med Res Opin 22(7): 1343-1351.
8. Burns M, Shanaman JE, Shellenberger CH. 1994. A laboratory study of patients with chronic allergic rhinitis: antihistamine effects on skilled performance. J Allergy Clin Immunol 93(4): 716-724.
9. Gandon JM, Allain H. 2002. Lack of effect of single and repeated doses of levocetirizine, a new antihistamine drug, on cognitive and psychomotor functions in healthy volunteers. Br J Clin Pharmacol 54: 51-58.
10. Gupta R, Sheikh A, Strachan DP, Anderson HR. 2006. Time trends in allergic disorders in the UK. Thorax 62: 91-96.
11. Hindmarch I. 2002. CNS effects of antihistamines: is there a third generation of non-sedative drugs? Clin Exp Allergy Rev 2(1):26-31.
12. Hindmarch I, Shamsi Z. 2001. The effects of single and repeated administration of ebastine in cognition and psychomotor performance in comparison to triprolidine and placebo in healthy volunteers. Curr Med Res Opin 17(4): 273-281.
13. Hindmarch I, Johnson S, Meadows R, Kirkpatrick T, Shamsi Z. 2001. The acute and sub-chronic effects of levocetirizine, cetirizine, loratadine, promethazine and placebo on cognitive function, psychomotor performance and weal and flare. Curr Med Res Opin 17(4): 241-255.
14. Hindmarch I, Shamsi Z, Kimber S. 2002. An evaluation of the effects of high-dose fexofenadine on the central nervous system: a double-blind, placebo-controlled study in healthy volunteers. Clin Exp Allergy 32: 133-139.
15. Jones NS, Smith PA, Carney SA, Davis A. 1998. The prevalence allergic rhinitis and symptoms in Nottingham. Clin Otolaryngol and Allied Sci 23: 547-554.
16. Kamei H, Noda Y, Ishikawa K, et al. 2003. Comparative study of acute effects of single doses of fexofenadine, olopatadine, d-chlorpheniramine and placebo on psychomotor function in healthy volunteers. Hum Psychopharmacol Clin Exp 18: 611-618.
17. Kay GG. 2000. The effects of antihistamines on cognition and performance. J Allergy Clin Immunol 105: S622-S627.
18. Layton D, Wilton L, Boshier A, Cornelius V, Harris S, Shakir SAW. 2006. Comparison of the risk of drowsiness and sedation between levocetirizine and desloratadine - A prescription-event monitoring study in England. Drug Safety 29(10): 897-909.
19. Mann RD, Pearce GL, Dunn N, Shakir S. 2000. Sedation with 'non-sedating' antihistamines: four prescription-event monitoring studies in general practice. BMJ 320: 1184-1187.
20. Mansfield L, Mendoza C, Flores J, Meeves SG. 2003. Effects of fexofenadine, diphenhydramine, and placebo on performance the test of variables of attention (TOVA). Ann Allergy Asthma Immunol 90: 554-559.
21. Marshall PS, O'Hara C, Steinberg P. 2000. Effects of seasonal allergic rhinitis on selected cognitive abilities. Ann Allergy Asthma Immunol 84(4): 403-410.
22. Meltzer EO. 2001. Quality of life in adults and children with allergic rhinitis. J Allergy Clin Immunol 108: S45-S53.
23. Nathan RA. 2006. The burden of allergic rhinitis. Allergy Asthma Proc 28: 3-9.
24. National Prescribing Centre. 2004. Common questions about hay fever. MeReC Bull 14(5): 17-20.
25. Nicholson AN, Handford ADF, Turner C, Stone B. 2003. Studies on performance and sleepiness with the H1-antihistamine, desloratadine. Aviat Space Environ Med 74(8): 809-815.
26. Paul MA, MacLellan M, Gray G. 2005. Motion-sickness medications for aircrew: impact on psychomotor performance. Aviat Space Environ Med 76(6): 560-565.
27. Ridout F, Hindmarch I. 2002. The effects of acute doses of fexofenadine, promethazine, and placebo on cognitive and psychomotor function in healthy Japanese volunteers. Ann Allergy Asthma Immunol 90: 404-410.
28. Ridout F, Shamsi Z, Meadows R, Johnson S, Hindmarch I. 2003. A single-centre, randomized, double-blind, placebo-controlled, crossover investigation of the effects of fexofenadine hydrochloride 180 mg alone and with alcohol, with hydroxyzine hydrochloride as a positive internal control, on aspects of cognitive and psychomotor function related to driving a car. Clin Ther 25(5): 1518-1538.
29. Schoenwetter WF, Dupclay L Jr, Appajosyula S, Botteman MF, Pashos CL. 2004. Economic impact and quality of life burden or allergic rhinitis. Curr Med Res Opin 20: 305-317.
30. Shamsi Z, Hindmarch I. 2000. Sedation and Antihistamines: a Review of Inter-Drug Differences using Proportional Impairment Ratios. Hum Psychopharmacol Clin Exp 15: S3-S30.
31. Shamsi Z, Kimber S, Hindmarch I. 2001. An investigation into the effects of cetirizine on cognitive function and psychomotor performance in healthy volunteers. Eur J Clin Pharmacol 56: 865-871.
32. 1-receptor antagonists. Clin Exp Allergy 26(9): 1092-1097.
33. Spaeth J, Klimek L, Mosges R. 1996. Sedation in allergic rhinitis is caused by the condition and not by antihistamine treatment. Allergy 51(12): 893-906.
34. Starmer G. 1985. Antihistamines and highway safety. Accid Anal Prev 17(4): 311-317.
35. Stather R. 1998. Update on collecting ADRs and new methods of signal generation. Reactions 718: 3-5.
36. Strachan DP. 2000. Epidemiology of rhinitis. In Asthma and Rhinitis, 2nd edn, Busse WW, Holgate ST (eds). Blackwell Science Ltd: London; 33-42.
37. Tagawa M, Kano M, Okamura N, et al. 2001. Differential cognitive effects of ebastine and (+)-chlorpheniramine in healthy subjects: correlation between cognitive impairment and plasma drug concentration. Br J Clin Pharmacol 53: 296-304.
38. Tashiro M, Sakurada Y, Iwabuchi K, et al. 2004. Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using C-Doxepin positron emission topography. J. Clin Pharmacol 44: 890-900.
39. Tashiro M, Horikawa E, Mochizuki H, et al. 2005. Effects of fexofenadine and hydroxyzine on brake reaction time during car-driving with cellular phone use. Hum Psychopharmacol Clin Exp 20(7): 501-509.
40. Theunissen EL, Vermeeren A, van Oers ACM, van Maris I, Ramaekers JG. 2004. A dose ranging study of the effects of mequitazine on actual driving, memory and psychomotor performance as compared to dexchlorpheniramine, cetirizine and placebo. Clin Exp Allergy 34: 250-258.
41. Theunissen EL, Vermeeren A, Ramaekers JG. 2006. Repeated-dose effects of mequitazine, cetirizine and dexchlorpheniramine on driving and psychomotor performance. Br J Clin Pharmacol 61(1): 79-86.
42. Turner C, Handford ADF, Nicholson AN. 2006. Sedation and memory: studies with a histamine H-1 receptor antagonist. J. Psychopharmacol 20(4): 506-517.
43. Upton M, McConnachie A, McSharry C, et al. 2000. Intergenerational 20 year trends in the prevalence of asthma and hay fever in adults: the Midspan family study surveys of parents and offspring. BMJ 321: 88-92.
44. Valk PJL, Van Roon DB, Simons RM, Rikken G. 2004. Desloratadine shows no effect on performance during 6 h at 8,000 ft simulated cabin altitude. Aviat Space Environ Med 75(5): 433-438.
45. Vermeeren A, Ramaekers JG, O'Hanlon JF. 2002. Effects of emedastine and cetirizine, alone and with alcohol, on actual driving of males and females. J. Psychopharmacol 16(1): 57-64.
46. Verster JC, Volkerts ER, van Oosterwijck AWAA, et al. 2002. Acute and subchronic effects of levocetirizine and diphenhydramine on memory functioning, psychomotor performance, and mood. J. Allergy Clin Immunol 111(3): 623-627.
47. Verster JC, de Weert AM, Bijtjes SIR, et al. 2003. Driving ability after acute and subchronic administration of levocetirizine and diphenhydramine: a randomized, double-blind, placebo-controlled trial. Psychopharmacol 169: 84-90.
48. Vuurman EFPM, Rikken GHY, Muntjewerff ND, de Halleux F, Ramaekers JG. 2004. Effects of desloratadine, diphenhydramine, and placebo on driving performance and psychomotor performance measurements. Eur J Clin Pharmacol 60: 307-313.